The "Glaucoma Freedom" Era: Is 2026 the Year We Finally Kill the Eye Drop?
A major shift in the 2026 global industry is the implementation of "MIGS-Plus" (Micro-Invasive Glaucoma Surgery). This year, to cater to the millions of patients who struggle with daily drops, the Ocular Implants Market has shifted toward Injectable Reservoirs that sit inside the eye and slowly leak medication for up to three years. This level of "Set-and-Forget Therapy" is the new gold...
0 Reacties 0 aandelen 8 Views 0 voorbeeld
Lifesone https://lifesone.com